Copyright
©The Author(s) 2023.
World J Clin Cases. Oct 16, 2023; 11(29): 7075-7081
Published online Oct 16, 2023. doi: 10.12998/wjcc.v11.i29.7075
Published online Oct 16, 2023. doi: 10.12998/wjcc.v11.i29.7075
Group | n | CD4+ | CD8+ | Tregs |
Incipient | 79 | 32.67 ± 11.11 | 39.26 ± 9.06 | 6.32 ± 3.21 |
Effectively treated | 45 | 28.63 ± 4.07 | 38.59 ± 9.14 | 5.1 ± 2.02 |
Relapse-refractory | 34 | 38.01 ± 14.76 | 40.15 ± 9.00 | 7.95 ± 3.76 |
Control | 30 | 26.15 ± 5.84 | 37.14 ± 8.14 | 4.11 ± 2.26 |
F value | 9.439c | 0.671 | 10.736c | |
P value | < 0.001 | 0.571 | < 0.001 | |
Multiple comparison | The proportion of CD4+ cells was higher in the incipient and relapsed-refractory groups than in the effectively treated and normal control groups. | / | The proportion of Tregs was higher in the incipient and relapsed-refractory groups than in the effectively treated and normal control groups. |
- Citation: Wu H, Sun HC, Ouyang GF. Effect of T-regulatory cells and interleukin-35, interleukin-10, and transforming growth factor-beta on diffuse large B-cell lymphoma. World J Clin Cases 2023; 11(29): 7075-7081
- URL: https://www.wjgnet.com/2307-8960/full/v11/i29/7075.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i29.7075